[1]
|
McKibbin, M., Isaacs, J.D. and Morrell, A.J. (1999) Incidence of Corneal Melting in Association with Systemic Disease in the Yorkshire Region, 1995-7. British Journal of Ophthalmology, 83, 941-943.
https://doi.org/10.1136/bjo.83.8.941
|
[2]
|
Odorcic, S., Keystone, E.C. and Ma, J.J.K. (2009) Infliximab for the Treatment of Refractory Progressive Sterile Peripheral Ulcerative Keratitis Associated with Late Corneal Perforation: 3-Year Follow-Up. Cornea, 28, 89-92.
https://doi.org/10.1097/ICO.0b013e318181a84f
|
[3]
|
Ladas, J.G. and Mondino, B.J. (2000) Systemic Disorders Associated with Peripheral Corneal Ulceration. Current Opinion in Ophthalmology, 11, 468-471. https://doi.org/10.1097/00055735-200012000-00014
|
[4]
|
Akpek, E.K., Thorne, J.E., Qazi, F.A., et al. (2004) Evaluation of PATIENTS with Scleritis for Systemic Disease. Ophthalmology, 111, 501-506. https://doi.org/10.1016/j.ophtha.2003.06.006
|
[5]
|
Tauber, J., Sainz, D.L.M., Hoang-Xuan, T., et al. (1990) An Analysis of Therapeutic Decision Making Regarding Immunosuppressive Chemotherapy for Peripheral Ulcerative Keratitis. Cornea, 9, 66-73.
https://doi.org/10.1097/00003226-199001000-00013
|
[6]
|
Messmer, E.M. and Foster, C.S. (1999) Vasculitic Peripheral Ulcerative Keratitis. Survey of Ophthalmology, 43, 379-396. https://doi.org/10.1016/S0039-6257(98)00051-4
|
[7]
|
Foster, C.S., Forstot, S.L. and Wilson, L.A. (1984) Mortality Rate in Rheumatoid Arthritis Patients Developing Necrotizing Scleritis or Peripheral Ulcerative Keratitis. Effects of Systemic Immunosuppression. Ophthalmology, 91, 1253-1263.
https://doi.org/10.1016/S0161-6420(84)34160-4
|
[8]
|
Gupta, Y., Kishore, A., Kumari, P., et al. (2021) Peripheral Ulcerative Keratitis. Survey of Ophthalmology, 66, 977-998.
https://doi.org/10.1016/j.survophthal.2021.02.013
|
[9]
|
Gonzalez, G., Sasamoto, Y., Ksander, B.R., et al. (2017) Limbal Stem Cells: Identity, Developmental Origin, and Therapeutic Potential. Wiley Interdisciplinary Reviews: Developmental Biology, 7, e303.
https://doi.org/10.1002/wdev.303
|
[10]
|
Robin, J.B., Schanzlin, D.J., Verity, S.M., et al. (1986) Peripheral Corneal Disorders. Survey of Ophthalmology, 31, 1-36. https://doi.org/10.1016/0039-6257(86)90049-4
|
[11]
|
Marsovszky, L., Resch, M.D., Németh, J., Toldi, G., et al. (2013) In Vivo Confocal Microscopic Evaluation of Corneal Langerhans Cell Density, and Distribution and Evaluation of Dry Eye in Rheumatoid Arthritis. Innate Immunity, 19, 348-354. https://doi.org/10.1177/1753425912461677
|
[12]
|
Messmer, E.M. and Foster, C.S. (1995) Destructive Corneal and Scleral Disease Associated with Rheumatoid Arthritis. Medical and Surgical Management. Cornea, 14, 408-417. https://doi.org/10.1097/00003226-199507000-00010
|
[13]
|
Müller, L.J., Pels, E., Schurmans, L., et al. (2004) A New Three-Dimensional Model of the Organization of Proteoglycans and Collagen Fibrils in the Human Corneal Stroma. Experimental Eye Research, 78, 493-501.
https://doi.org/10.1016/S0014-4835(03)00206-9
|
[14]
|
Müller, L.J., Vrensen, G.F., Pels, L., et al. (1997) Architecture of Human Corneal Nerves. Investigative Ophthalmology & Visual Science, 38, 985-994.
|
[15]
|
Dana, M.R., Qian, Y. and Hamrah, P. (2000) Twenty-Five-Year Panorama of Corneal Immunology: Emerging Concepts in the Immunopathogenesis of Microbial Keratitis, Peripheral Ulcerative Keratitis, and Corneal Transplant Rejection. Cornea, 19, 625. https://doi.org/10.1097/00003226-200009000-00008
|
[16]
|
Foster, C.S., Kenyon, K.R., Greiner, J., et al. (1979) The Immunopathology of Mooren’s Ulcer. American Journal of Ophthalmology, 88, 149-159. https://doi.org/10.1016/0002-9394(79)90459-8
|
[17]
|
Mondino, B.J., Brown, S.I. and Rabin, B.S. (1978) Cellular Immunity in Mooren’s Ulcer. American Journal of Ophthalmology, 85, 788-791. https://doi.org/10.1016/S0002-9394(14)78106-1
|
[18]
|
Mondino, B.J. (1988) Inflammatory Diseases of the Peripheral Cornea. Ophthalmology, 95, 463-472.
https://doi.org/10.1016/S0161-6420(88)33164-7
|
[19]
|
Keenan, J.D., Mandel, M.R. and Margolis, T.P. (2011) Peripheral Ulcerative Keratitis Associated with Vasculitis Manifesting Asymmetrically as Fuchs Superficial Marginal Keratitis and Terrien Marginal Degeneration. Cornea, 30, 825.
https://doi.org/10.1097/ICO.0b013e3182000c94
|
[20]
|
Gregory, J.K. and Foster, C.S. (1996) Peripheral Ulcerative Keratitis in the Collagen Vascular Diseases. International Ophthalmology Clinics, 36, 21-30. https://doi.org/10.1097/00004397-199603610-00005
|
[21]
|
Fernandes, S.R.M., Singsen, B.H. and Hoffman, G.S. (2000) Sarcoidosis and Systemic Vasculitis. Seminars in Arthritis & Rheumatism, 30, 33-46. https://doi.org/10.1053/sarh.2000.8364
|
[22]
|
Riley, G.P., Harrall, R.L., Watson, P.G., et al. (1995) Collagenase (MMP-1) and TIMP-1 in Destructive Corneal Disease Associated with Rheumatoid Arthritis. Eye, 9, 703. https://doi.org/10.1038/eye.1995.182
|
[23]
|
Perry, H.D. and Golub, L.M. (1986) Systemic Tetracyclines in the Treatment of Noninfected Corneal Ulcers: A Case Report and Proposed New Mechanism of Action. Annals of Ophthalmology, 17, 742-744.
|
[24]
|
Ralph, R.A. (2000) Tetracyclines and the Treatment of Corneal Stromal Ulceration. Cornea, 19, 274-277.
https://doi.org/10.1097/00003226-200005000-00003
|
[25]
|
Kaçmaz, R.O., Kempen, J.H., Newcomb, C., et al. (2010) Cyclosporine for Ocular Inflammatory Diseases. Ophthalmology, 117, 576-584. https://doi.org/10.1016/j.ophtha.2009.08.010
|
[26]
|
Golub, L.M. (1991) Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications for an Old Family of Drugs. Critical Reviews in Oral Biology and Medicine: An Official Publication of the American Association of Oral Biologists, 2, 297-321. https://doi.org/10.1177/10454411910020030201
|
[27]
|
Galor, A. and Thorne, J.E. (2007) Scleritis and Peripheral Ulcerative Keratitis. Rheumatic Disease Clinics of North America, 33, 835-854. https://doi.org/10.1016/j.rdc.2007.08.002
|
[28]
|
Jabs, D.A., Rosenbaum, J.T., Foster, C.S., et al. (2000) Guidelines for the Use of Immunosuppressive Drugs in Patients with Ocular Inflammatory Disorders: Recommendations of an Expert Panel. American Journal of Ophthalmology, 130, 492-513. https://doi.org/10.1016/S0002-9394(00)00659-0
|
[29]
|
Sainz de la Maza, M., Foster, C.S., Jabbur, N.S. and Baltatzis, S. (2002) Ocular Characteristics and Disease Associations in Scleritis-Associated Peripheral Keratopathy. Archives of Ophthalmology, 120, 15-19.
https://doi.org/10.1001/archopht.120.1.15
|
[30]
|
Squirrell, D.M., Winfield, J. and Amos, R.S. (1999) Peripheral Ulcerative Keratitis “Corneal Melt” and Rheumatoid Arthritis: A Case Series. Rheumatology, 38, 1245-1248. https://doi.org/10.1093/rheumatology/38.12.1245
|
[31]
|
Messmer, E.M. and Foster, C.S. (1999) Vasculitic Peripheral Ulcerative Keratitis. Survey of Ophthalmology, 43, 379-396. https://doi.org/10.1016/S0039-6257(98)00051-4
|
[32]
|
Sato, T., Minakuchi, S., Mochizuki, M. and Takeuchi, M. (2014) Acute Anterior Uveitis after Discontinuation of Tocilizumab in a Patient with Rheumatoid Arthritis. Clinical Ophthalmology, 8, 187-190.
https://doi.org/10.2147/OPTH.S54929
|
[33]
|
Stylianides, A., Jones, M.N., Stewart, R.M., et al. (2013) Rheumatoid Arthritis-Associated Corneal Ulceration: Mortality and Graft Survival. Ophthalmology, 120, 682-686. https://doi.org/10.1016/j.ophtha.2012.09.050
|
[34]
|
Galor, A., Jabs, D.A., Leder, H.A., et al. (2008) Comparison of Antimetabolite Drugs as Corticosteroid-Sparing Therapy for Noninfectious Ocular Inflammation. Ophthalmology, 115, 1826-1832.
https://doi.org/10.1016/j.ophtha.2008.04.026
|
[35]
|
Mccarthy, J.M., Dubord, P.J., Chalmers, A., et al. (1992) Cyclosporine A for the Treatment of Necrotizing Scleritis and Corneal Melting in Patients with Rheumatoid Arthritis. Journal of Rheumatology, 19, 1358-1361.
|
[36]
|
Thomas, J.W. and Pflugfelder, S.C. (2005) Therapy of Progressive Rheumatoid Arthritis-Associated Corneal Ulceration with Infliximab. Cornea, 24, 742. https://doi.org/10.1097/01.ico.0000154391.28254.1d
|
[37]
|
Antao, S.F., Ayoub, T., Tahir, H., et al. (2012) Stabilization of Bilateral Progressive Rheumatoid Corneal Melt with Infliximab. Case Reports in Ophthalmological Medicine, 2012, Article ID: 173793.
https://doi.org/10.1155/2012/173793
|
[38]
|
Atchia, I.I., Kidd, C.E. and Bell, R.W.D. (2006) Rheumatoid Arthritis-Associated Necrotizing Scleritis and Peripheral Ulcerative Keratitis Treated Successfully with Infliximab. Journal of Clinical Rheumatology Practical Reports on Rheumatic & Musculoskeletal Diseases, 12, 291-293. https://doi.org/10.1097/01.rhu.0000249766.24780.95
|
[39]
|
Kawabata, Y., Miyaji, Y., Nakano, T., et al. (2012) A Change in Treatment from Etanercept to Infliximab Was Effective to Control Scleritis in a Patient with Rheumatoid Arthritis. Acta Ophthalmologica, 90, e161-e162.
https://doi.org/10.1111/j.1755-3768.2010.02090.x
|
[40]
|
Ashok, D., Ayliffe, W.H. and Kiely, P. (2005) Necrotizing Scleritis Associated with Rheumatoid Arthritis: Long-Term Remission with High-Dose Infliximab Therapy. Rheumatology, 44, 950-951.
https://doi.org/10.1093/rheumatology/keh635
|
[41]
|
Smith, J.R., Levinson, R., Holland, G.N., et al. (2001) Differential Efficacy of Tumor Necrosis Factor Inhibition in the Management of Inflammatory Eye Disease and Associated Rheumatic Disease. Arthritis & Rheumatology, 45, 252-257.
https://doi.org/10.1002/1529-0131(200106)45:3<252::AID-ART257>3.0.CO;2-5
|
[42]
|
García, C.C., Rosso, M.L., Bertoni, M.D., et al. (2017) Necrotising Scleritis and Peripheral Ulcerative Keratitis Associated with Rheumatoid Arthritis Treated with Rituximab. KlinischeMonatsblätter für Augenheilkunde, 234, 567-570.
https://doi.org/10.1055/s-0042-121315
|
[43]
|
Freidlin, J., Wong, I.G. and Acharya, N. (2007) Rituximab Treatment for Peripheral Ulcerative Keratitis Associated with Wegener’s Granulomatosis. British Journal of Ophthalmology, 91, 1414. https://doi.org/10.1136/bjo.2006.113316
|
[44]
|
Feder, R.S. and Krachmer, J.H. (1984) Conjunctival Resection for the Treatment of the Rheumatoid Corneal Ulceration. Ophthalmology, 91, 111-115. https://doi.org/10.1016/S0161-6420(84)34319-6
|
[45]
|
Vera, L., Benzerroug, M., Gueudry, J., et al. (2009) Mise au point sur l’utilisation des colles tissulaires en ophtalmologie. Journal Français d’Ophtalmologie, 32, 290-305. https://doi.org/10.1016/j.jfo.2009.01.008
|
[46]
|
Maeno, A., Naor, J., Lee, H.M., Hunter, W.S. and Rootman, D.S. (2000) Three Decades of Corneal Transplantation: Indications and Patient Characteristics. Cornea, 19, 7-11. https://doi.org/10.1097/00003226-200001000-00002
|
[47]
|
Artifoni, M., et al. (2014) Ocular Inflammatory Diseases Associated with Rheumatoid Arthritis. Nature Reviews Rheumatology, 10, 108-116. https://doi.org/10.1038/nrrheum.2013.185
|